Penn State Milton S. Hershey Medical Center’s Department of Emergency Medicine has completed its participation in a clinical research study called RAMPART, Rapid Anticonvulsant Medications Prior to Arrival Trial. This nation-wide study has reached its enrollment target and has stopped enrolling patients across the country. RAMPART was an EMS trial designed to study if seizure drug given as a shot in the muscle was just as effective as seizure drug given through an IV into the vein at stopping seizures.

Residents within the communities served by LifeLion EMS who opted-out of the trial by wearing a “RAMPART Declined” bracelet can now stop wearing this bracelet.
Results of this study will be released to the local public and will also be available on the Hershey Medical Center’s Web site at PennStateHershey.org after the data have been analyzed.
For more information, contact Stacey Cleary at 717-531-1707 option 1. 

Learn more about RAMPART: